imo it was the right move by middlemas. tough decision but clinical - what you'd expect from a decent ceo.
imagine if the re-assessment hadn't been done. we could have gone further down the track with medinandi and compounded the losses only to find out much later that we had even less than we thought.
the dead weight has been cut and set free. i'm not looking in the rear-view mirror any more. onwards with fekola.